Which is the scientific rationale for administering the 5-alpha-reductase inhibitor dutasteride (AVODART) to a client diagnosed with benign prostatic hypertrophy (BPH)? 1. The medication elevates male...

Which is the scientific rationale for administering the 5-alpha-reductase inhibitor dutasteride (AVODART) to a client diagnosed with benign prostatic hypertrophy (BPH)?

1. The medication elevates male testosterone levels and decreases impotence. 2. AVODART causes a rapid reduction in the size of the prostate and relief of symptoms. 3. The medication decreases the mechanical obstruction of the urethra by the prostate. 4. AVODART is as fast as surgery in reducing the obstructive symptoms of BPH.